Nevertheless, it was confirmed that the Th2Low subgroup with lower expression of PD-L1, PD-L2, and PD-1 was associated with the best prognosis among all the subgroups in the two independent GBM data sets. The gene discussed is PDCD1LG2; the disease is glioblastoma.